Total
0
Shares
OncoSil Medical (ASX:OSL) - Managing Director & CEO, Daniel Kenny - The Market Herald
Managing Director & CEO, Daniel Kenny
Sourced: Finance News Network
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Oncosil Medical (OSL) has been granted Hong Kong regulatory approval for its namesake device as a treatment for pancreatic cancer
  • Oncosil is a targeted radioactive isotope, implanted into locally advanced pancreatic tumours via an endoscopic ultrasound
  • The approval gives the company access to a key market in its ASEAN commercialisation strategy and follows approvals from Singapore and Malaysia
  • Oncosil is also awaiting the outcome of its application to the Australian regulator
  • Shares closed 4.3 per cent higher at 9.8 cents

Oncosil Medical (OSL) has been granted Hong Kong regulatory approval for its namesake device as a treatment for pancreatic cancer.

Oncosil is a targeted radioactive isotope and works by being implanted directly into the locally advanced pancreatic tumour via an endoscopic ultrasound.

The approval from the Medical Device Division of the Department of Health allows the company to market and sell the device in Hong Kong.

Oncosil views the market as strategic due to the small number of hospitals treating the disease and the elevated healthcare spending per capita relative to other countries in the region.

Oncosil also described the approval as a key step in its ASEAN commercialisation strategy. It follows approvals from regulators in Singapore and Malaysia last year.

The company is awaiting the outcome of its application to the Australian regulator, the Therapeutic Goods Administration.

Shares closed 4.3 per cent higher at 9.8 cents.

OSL by the numbers
More From The Market Herald
AnteoTech (ASX:ADO) - CEO, Derek Thomson - The Market Herald

" AnteoTech (ASX:ADO) signs COVID-19 test manufacturing contract

AnteoTech (ADO) has finalised and signed a contract manufacturing agreement with Spanish manufacturer, Operon.
Botanix Pharmaceuticals (ASX:BOT) - President & Executive Chairman, Vince Ippolito - The Market Herald

" Botanix Pharmaceuticals (ASX:BOT) receives encouraging results from canine study

Botanix Pharmaceuticals (BOT) says it has received encouraging results from a small pilot study of its synthetic CBD treatment in canines with atopic
Healthia (ASX:HLA) to purchase The Eyecare Place

" Healthia (ASX:HLA) to purchase The Eyecare Place

Healthia (HLA) has entered into agreements to purchase The Eyecare Place, an optical store located in Abbotsford, Victoria.
Avita Therapeutics (ASX:AVH) - CEO, Dr Michael Perry - The Market Herald

" Avita Medical (ASX:AVH) reports solid revenue growth over March quarter

Avita Medical (AVH) reported a 126-per-cent revenue increase and steady growth in procedural volumes in its review of the March quarter.